Device Trial Radar · NCT02326402
TandemHeart Experiences and MEthods (THEME Registry)
Last checked: Nov 20, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- CardiacAssist, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 29, 2014
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is intended to be a multicenter, prospective observation registry. By collecting prospective descriptive data, provide insight into disease defining characteristics resulting in the clinical decision to use TandemHeart® or LifeSPARC™ System for mechanical support and enhance knowledge of best practice regarding clinical management, weaning and removal/exit strategies.
Conditions
- Heart Diseases
- Lung Diseases
Interventions
TandemHeart or LifeSPARC SystemDevice
Percutaneous insertion of TandemHeart or LifeSPARC System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival to Pump removal with myocardial and/or pulmonary recovery, durable ventricular assist device (VAD) implant or transition to another mechanical support device, or cardiac and/or lung transplantTime frame: 180 Days
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Princeton-Baptist Medical Center
Birmingham, Alabama
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.